MiniMed Group, Inc. (MMED)
NASDAQ · Healthcare
$16.92-0.06%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $4.49B
- P/E ratio
- —
- EPS
- —
- Volume
- 1,137,184
- 52-week high
- —
- 52-week low
- —
- Open
- $16.93
- Day high
- $17.33
- Day low
- $16.80
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2026 | $3.1B | -$333M | -$1.30 |
| 2025 | $2.72B | -$213M | -$0.84 |
| 2024 | $2.47B | -$112M | -$0.44 |
About MiniMed Group, Inc.
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
- CEO
- Que Thanh Dallara
- Employees
- 8,000
- Country
- US
- IPO date
- Mar 5, 2026
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is MiniMed Group, Inc.'s stock price today?
- MMED is trading at $16.92 as of Jul 20, 2026.
- What is MiniMed Group, Inc.'s market cap?
- MiniMed Group, Inc. (MMED) has a market capitalization of $4.49B.
- Does MiniMed Group, Inc. pay a dividend?
- MiniMed Group, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is MiniMed Group, Inc. in?
- MiniMed Group, Inc. operates in the Healthcare sector.